# A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant

> **NCT06213818** · PHASE1 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 137 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** INCB160058
- **DRUG:** Placebo
- **DRUG:** Esomeprazole
- **DRUG:** Famotidine

## Key facts

- **NCT ID:** NCT06213818
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-14
- **Primary completion:** 2025-08-19
- **Final completion:** 2025-08-19
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06213818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06213818, "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06213818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*